Skip to main content
Veterinary Medicines

Advantage Dog 40 40 mg/0.4 ml Oplossing voor cutaan gebruik

Authorised
  • Imidacloprid

Product identification

Medicine name:
Advantage Dog 40 40 mg/0.4 ml Oplossing voor cutaan gebruik
Advantage Dog 40 40 mg/0.4 ml Solution pour application cutanée
Advantage Dog 40 40 mg/0.4 ml Lösung zur Anwendung auf der Haut
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Advantage Dog 40 6 Pipettes with 0.4 ml Cutaneous solution
  • Advantage Dog 40 4 Pipettes with 0.4 ml Cutaneous solution
  • Advantage Dog 40 3 Pipettes with 0.4 ml Cutaneous solution
  • Advantage Dog 40 2 Pipettes with 0.4 ml Cutaneous solution

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V459680
Date of authorisation status change:
Informed consent reference:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025